Saturday, November 10, 2012 Friday, November 9, 2012- Does VIVUS Need a Partner?at Motley Fool (Fri, Nov 9)
- Cramer: Sell Changyou.com and Buy Abbott Labs, Henry Schein and These 2 Sizzling Shares Todayat Wall St. Cheat Sheet (Fri, Nov 9)
- 3 Healthcare Stocks To Add To A Portfolio During Times Of Market Volatilityat Seeking Alpha (Fri, Nov 9)
- Has Abbott Labs Become the Perfect Stock?at Motley Fool (Fri, Nov 9)
- Oracle Reaches for the Clouds With This Acquisitionat Wall St. Cheat Sheet (Fri, Nov 9)
- Biotech Stock Mailbag: Sarepta, Acadia, Vical and a Hep C Previewat TheStreet (Fri, Nov 9)
- Cramer's Top Stock Picks: ABT AFCE HSICat TheStreet (Fri, Nov 9)
Thursday, November 8, 2012- Canada Unites Against Pfizerat Motley Fool (Thu, Nov 8)
- Cramer's 'Mad Money' Recap: Pros and Consat TheStreet (Thu, Nov 8)
- Abbott Laboratories (ABT): Today's Featured Drugs Laggardat TheStreet (Thu, Nov 8)
- 1 Reason to Buy Amarin Right Now, and 1 Reason to Sellat Motley Fool (Thu, Nov 8)
- Abbott: A Lucrative Play On Strong Revenue Growthat Seeking Alpha (Thu, Nov 8)
- Abbott: Waiting To Buy This Healthcare Stockat Seeking Alpha (Thu, Nov 8)
- Best And Worst ETFs And Mutual Funds: All-Cap Value Styleat Seeking Alpha (Thu, Nov 8)
- Has Savient Pharmaceuticals Become the Perfect Stock?at Motley Fool (Thu, Nov 8)
- The Most Promising Dividends in Pharmaceutical Companiesat Motley Fool (Thu, Nov 8)
- Obama Win Exposes Medical Stocks to QE Fatigueat TheStreet (Thu, Nov 8)
- [video] A Closer Look at Abbott Labsat TheStreet (Thu, Nov 8)
Wednesday, November 7, 2012Add ABT News to My Yahoo!  | |
|